Clifford Chance
Global Intellectual Property Newsletter - 19th Issue - IP and Pharma
26 September 2018
Welcome to the 19th edition of Clifford Chance's Global IP Newsletter. We will be providing you with a special edition focusing on Healthcare and Pharma around the globe, as well as other recent notable cases and legislation.
- Spain: The Barcelona Court of Appeal clarifies that "Swiss Claims" were not affected by the Spanish Reservation to the EPC
- Germany: German courts strengthened protection of Second-Medical-Use patents
- Italy: Patent Linkage: the Italian way
- Australia: A Bitter Pill to Swallow…Compensation Claims on Big Pharma Damages Undertakings
- Germany: The Supplementary Protection Certificate – overview of the latest case law by ECJ and German courts
- Spain: Eroding Supplementary Protection Certificates? The controversial "manufacturing exception for export purposes" proposed by the Commission of the European Union
- Germany: Overview of the promising market of medical cannabis in Germany
- France: Sufficiency of disclosure as a ground of patent nullity in French and European case law
- France: French statute of limitation in patent nullity actions
- Poland: Supreme Court provides answers to questions on the nature of copyright enforcement in Poland
